An AHASTAT blog post today takes issue with a recent report that attempts to link hospital prices and concentration based on commercial claims data from just three insurance companies, including one with only 30% of its enrollment mix in commercial products. “The paper is badly flawed and the assertions made about hospital market structure and prices, in particular, should be viewed as unreliable for a number of reasons,” writes Melinda Reid Hatton, AHA general counsel and senior vice president. “The data used are old (2008-2011) and predate the effects of public and some private payers shifting to value-based payments.” For a more in-depth analysis on the report by a leading health care economist, click here.

Related News Articles

Headline
New research released today by the Deloitte Center for Health Solutions and Healthcare Financial Management Association offers key strategies for achieving…
Headline
The Centers for Medicare & Medicaid Services seeks comments through Nov. 20 on a “new direction” for its Innovation Center that will approach…
Headline
AHA and AMGA members may apply through Oct. 20 to participate in an intensive learning collaborative on managing population health and succeeding in the new…
Headline
Anthem today asked the Supreme Court to review a federal appeals court decision blocking the health insurer’s proposed acquisition of Cigna.…
Headline
As urged by the AHA, the U.S. Court of Appeals for the District of Columbia Circuit today affirmed a district court decision blocking Anthem’s…
Headline
The House Judiciary Committee today voted 16-10 to approve the Standard Merger and Acquisition Reviews Through Equal Rules Act (H.R. 659), AHA-supported…